Skip to main content
. Author manuscript; available in PMC: 2018 Aug 12.
Published in final edited form as: Crit Rev Oncog. 2015;20(3-4):199–216. doi: 10.1615/critrevoncog.2015013566

TABLE 1:

Acquired SMARCB1 Alterations in 200 Sporadic Rhabdoid Tumors

Allele 1
Alteration
Allele 2 Alteration Total
Mutation Partial Gene
Deletion /
Duplication
Whole Gene
Deletion
CN-LOH
Mutation 8 (4%) 1 (0.50%) 58 (29%) 27 (13.5%) 94 (47%)
Partial gene
deletion /
duplication
5 (2.5%) 14 (7%) 11 (5.3%) 30 (15 %)
Whole gene
deletion
76 (38%) 76 (38%)
Total 8 (4%) 6 (3%) 148 (74%) 38 (19%) 200 (100%)

CN-LOH, copy number neutral loss of heterozygosity.